Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure

Neuropeptides

Volumn 35, Issue 3-4, 2001, Pages 174-180

  Strauss, G I ^a   Edvinsson, L ^b   Stolze Larsen, F ^a   Moller K ^a   Knudsen, G M ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; NEUROPEPTIDE; NEUROPEPTIDE Y; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; HYPERVENTILATION; LIVER CIRRHOSIS; LIVER FAILURE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN TRANSPORT; SYSTEMIC CIRCULATION;

EID: 0035182878     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1054/npep.2001.0861     Document Type: Article

References (35)

1. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: A retrospective study
2. Presence of neuropeptide Y in human circle of Willis and its possible role in cerebral vasospasm
3. Cerebral blood flow and liver function in patients with encephalopathy due to acute and chronic liver diseases
4. The influence of neurokinins and calcitonin gene-related peptide on cerebral blood flow in anaesthetized guinea-pigs
5. Increased circulating calcitonin gene-related peptide (CGRP) in cirrhosis
6. Degradation of vasoactive intestinal peptide by isolated, ventilated, and perfused rat lungs
7. Pathophysiology of cerebral edema in fulminant hepatic failure
8. Pharmacokinetics and organ-specific metabolism of calcitonin gene-related peptide in sheep
9. Hepatic inactivation of vasoactive intestinal peptide in man and dog
10. Preferential binding of vasoactive intestinal peptide to hepatic nonparenchymal cells
11. The trigemmovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats
12. Examination of the involvement of neuropeptide Y (NPY) in cerebral autoregulation using the novel NPY antagonist PP56
13. Calcitonin gene-related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation?
14. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment
15. Circulating endogenous vasoactive mtestinal polypeptide (VIP) in patients with uraemia and liver cirrhosis
16. Vasoactive intestinal polypeptide (VIP) in cirrhosis: Arteriovenous extraction in different vascular beds
17. Pharmacological evidence that calcitonin gene-related peptide is implicated in cerebral autoregulation
18. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat
19. Clearance of vasoactive intestinal polypeptide (VIP) in the porcine pulmonary circulation
20. Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man Involvement of sympathetic neuropeptide Y in cerebral vasospasm
21. Alterations in perivascular dilatory neuropeptides (CGRP,SP, VIP) in the external jugular vein and in the cerebrospinal fluid following subarachnoid haemorrhage in man
22. Nonsaturable entry of neuropeptide Y into brain
23. Blood-brain barrier permeability in galactosamine-induced hepatic encephalopathy No evidence for increased GABA-transport
24. Chronic parasympathetic sectioning decreases regional cerebral blood flow during hemorrhagic hypotension and increases infarct size after middle cerebral artery occlusion in spontaneously hypertensive rats
25. Cerebral circulation in liver failure: Ohm's law in force
26. Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure
27. Cerebral blood flow and the development of ammonia-induced brain edema in rats after portacaval anastomosis
28. Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide
29. Effect of hemodialysis on plasma levels of vasoactive peptides: Endothelin, calcitonin gene-related peptide and human atrial natriuretic peptide
30. Management of acute liver failure
31. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure
32. Transcranial Doppler Sonography and Internal Jugular Bulb Saturation during Hyperventilation in Patients with Fulminant Hepatic Failure
33. Neuropeptides in the cerebral circulation
34. Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects
35. Cerebral blood flow and metabolism in fulminant liver failure